Avoiding Malnutrition in the Era of Glucagon-Like Peptide-1 Medications: Emerging Evidence and Opportunities for Integrated Nutrition Care
Paola Mogna-Peláez, Marta Guasch-Ferré · 2026
Read Avoiding Malnutrition in the Era of Glucagon-Like Peptide-1 Medications: Emerging Evidence and Opportunities for Integrated Nutrition Care by Paola Mogna-Peláez, Marta Guasch-Ferré (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13494215.txt.
Description
Paola Mogna-Peláez and Marta Guasch-Ferré argue, in a 2026 perspective, that the swift spread of GLP-1 weight-loss drugs has left nutrition care behind. These drugs curb appetite and food intake sharply, which brings large weight loss and broad metabolic gains. The same curb can leave patients short on protein, key vitamins and minerals, and fiber, and can strip lean mass along with fat.
The authors note that diet checks are rare in daily practice even though obesity societies urge them. They make the case for dietitians and behavioral health staff as core members of the care team, able to keep nutrient intake sound and ease stomach side effects. Research needs include sound screening tools, clear nutrient targets, and profiles of patients at highest risk. With prescriptions now in the millions, they call the fix urgent rather than optional.
Catalog record
| CREATOR | Paola Mogna-Peláez, Marta Guasch-Ferré |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26824 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |